Urogen Pharma Ltd 's ability to collect accounts receivable sequentially worsen to 3.82, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Urogen Pharma Ltd 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 96 days, from 84 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 450 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2914, from overall ranking in the first quarter 2026 at 3190.

What is Receivable Turnover Ratio?
What is Urogen Pharma Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

URGN Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	351.71 %	182.17 %	62.95 %	-13.59 %	12.83 %
Y / Y Revenue Change	206.17 %	155.07 %	54.03 %	9.91 %	9.46 %
Receivable Turnover Ratio (TTM)	3.82	4.37	4.72	4.81	4.51
URGN's Total Ranking	# 2914	# 3190	# 2827	# 2956	# 3006
Accounts Receivable average collection period days	95	84	77	76	81
Seq. Receivable Change	60.18 %	67.5 %	67.9 %	0.27 %	0.06 %
Seq. Revenue Change	42.57 %	34.31 %	39.09 %	14.95 %	18.78 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 140
Healthcare Sector	# 451
Overall Market	# 2914

Receivable Turnover Ratio Statistics
High	Average	Low
5.96	5.18	3.82
(Dec 31 2022)		(Jun 30 2026)

URGN Company Profile • Back to URGN Efficiency Comparisons • Compare URGN Receivables Turnover Ratio to its Competitors

Financial Statements
Urogen Pharma Ltd 's Accounts Receivable	$ 89 Millions	Visit URGN's Balance sheet
Urogen Pharma Ltd 's Sales TTM	$ 188 Millions	Visit URGN's Income Statement
Sources of URGN's Revenues		Visit URGN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
URGN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
URGN's Growth Rates	URGN's Roa	URGN's Inventory Turnover Ratio	URGN's Dividend Comparisons
URGN's Profitability Ratios	URGN's Roi	URGN's Asset Turnover Ratio	URGN's Dividend Growth
URGN's Valuation Ratios	URGN's Roe	URGN's Financial Strength Ratios	URGN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Conmed Corporation	5.83	$ 1,371.657 Millions	$ 235.301 Millions
Infusystem Holdings Inc	5.83	$ 143.335 Millions	$ 24.599 Millions
Resmed Inc	5.80	$ 5,628.170 Millions	$ 970.458 Millions
Medtronic Plc	5.80	$ 37,542.000 Millions	$ 6,476.000 Millions
Gossamer Bio Inc	5.79	$ 53.286 Millions	$ 9.207 Millions
Pacific Health Care Organization Inc	5.78	$ 6.442 Millions	$ 1.114 Millions
Accuray Incorporated	5.77	$ 400.833 Millions	$ 69.455 Millions
Ispecimen inc	5.77	$ 0.466 Millions	$ 0.081 Millions
Bio rad Laboratories Inc	5.75	$ 2,589.000 Millions	$ 450.550 Millions
Evolus Inc	5.72	$ 317.113 Millions	$ 55.421 Millions
Prestige Consumer Healthcare Inc	5.72	$ 1,104.957 Millions	$ 193.142 Millions
Illumina Inc	5.71	$ 4,493.000 Millions	$ 787.000 Millions
Zai Lab Limited	5.71	$ 449.614 Millions	$ 78.789 Millions
Exagen Inc	5.70	$ 71.427 Millions	$ 12.532 Millions
Mettler toledo International Inc	5.69	$ 4,133.875 Millions	$ 726.298 Millions
Caribou Biosciences Inc	5.69	$ 10.035 Millions	$ 1.763 Millions
Standard Biotools Inc	5.64	$ 83.691 Millions	$ 14.838 Millions
Dentsply Sirona Inc	5.64	$ 3,643.000 Millions	$ 646.000 Millions
Community Health Systems Inc	5.63	$ 11,983.000 Millions	$ 2,129.500 Millions
Surgery Partners Inc	5.61	$ 3,366.300 Millions	$ 600.375 Millions
Bioxcel Therapeutics Inc	5.59	$ 0.742 Millions	$ 0.133 Millions
Integer Holdings Corporation	5.57	$ 1,842.621 Millions	$ 330.687 Millions
Jazz Pharmaceuticals Plc	5.56	$ 4,601.233 Millions	$ 828.078 Millions
Intelligent Bio Solutions Inc	5.51	$ 4.215 Millions	$ 0.765 Millions
Johnson and Johnson	5.47	$ 97,929.000 Millions	$ 17,889.000 Millions
Merck and Co Inc	5.47	$ 66,569.000 Millions	$ 12,167.250 Millions
Quanterix Corporation	5.45	$ 152.716 Millions	$ 28.030 Millions
Brightspring Health Services Inc	5.45	$ 5,877.918 Millions	$ 1,079.324 Millions
Charles River Laboratories International inc	5.44	$ 3,998.987 Millions	$ 734.654 Millions
Viskase Holdings inc	5.44	$ 177.054 Millions	$ 32.555 Millions

Date modified: 2026-09-09T22:40:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.